Cargando…
Early Detection of Pancreatic Cancer: Role of Biomarkers in Pancreatic Fluid Samples
Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related deaths worldwide. Most patients with PDAC present with symptomatic, surgically unresectable disease. Therefore, the establishment of strategies for the early detection is urgently needed. Molecular biomarkers might...
Autores principales: | Ideno, Noboru, Mori, Yasuhisa, Nakamura, Masafumi, Ohtsuka, Takao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762187/ https://www.ncbi.nlm.nih.gov/pubmed/33291257 http://dx.doi.org/10.3390/diagnostics10121056 |
Ejemplares similares
-
Is remnant pancreatic cancer after pancreatic resection more frequent in early‐stage pancreatic cancer than in advanced‐stage cancer?
por: Miyasaka, Yoshihiro, et al.
Publicado: (2020) -
Clinical significance of postpancreatectomy acute pancreatitis defined by the International Study Group for Pancreatic Surgery
por: Ikenaga, Naoki, et al.
Publicado: (2022) -
Use of Biomarkers and Imaging for Early Detection of Pancreatic Cancer
por: Kato, Shingo, et al.
Publicado: (2020) -
Circulating cancer‐associated extracellular vesicles as early detection and recurrence biomarkers for pancreatic cancer
por: Yoshioka, Yusuke, et al.
Publicado: (2022) -
Molecular Approaches Using Body Fluid for the Early Detection of Pancreatic Cancer
por: Satoh, Kennichi
Publicado: (2021)